NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.

about

The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis.NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?Dietary Melatonin Supplementation Could Be a Promising Preventing/Therapeutic Approach for a Variety of Liver Diseases

P2860

Q48326227-5C7B45C5-8347-46B4-B0E3-6B17107C6D3C Q54232638-42F1224B-6EAA-410C-BA5D-7BFC27977DAE Q58725798-EE153841-7E85-4299-A64C-02B030766A1E

P2860

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.

Item

http://www.wikidata.org/entity/Q38791719

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.

@en

type

Item

label

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.

@en

prefLabel

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.

@en

P1476

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.

@en

P2093

Stephen Caldwell

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Role of AMP-activated protein kinase in mechanism of metformin action

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

Vitamin E: function and metabolism

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis.

Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial.

P304

103-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3350/CMH.2017.0103

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28494529

http://www.w3.org/2001/XMLSchema#string

P921

lipid

Non-alcoholic fatty liver disease

mechanism of action

P932

5497667

http://www.w3.org/2001/XMLSchema#string

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.

about

P2860

P2860

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932